An international study, with the participation of the University of Zaragoza and the Aragón Health Research Institute (IIS Aragón), has tested a new therapeutic strategy to treat severe COVID. It is a clinical trial whose results are published in eClinicalMedicine and which could also be applied to other respiratory viruses.